Acupoint Application in Patients With Stable Angina Pectoris (AASAP)
Study Details
Study Description
Brief Summary
Hypothesis: acupoint application is effective for managing chronic stable angina pectoris. Aim: to evaluate the efficacy and safety of acupoint application on the specific acupoints for chronic stable angina pectoris. Design: A Randomized, Controlled,Double Blind trial. 200 participants will be included. Four arms: herbal medicine application on acupoint group , placebo application on acupoint group , herbal medicine application on non-acupoint group and placebo application on non-acupoint group.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Early Phase 1 |
Detailed Description
Acupoint application with herbal medicine is a kind of external treatment of traditional Chinese medicine and has a long history in China, which is use herbal medicine made of plaster and stick to specific acupoints, using the double effects of acupoints and herb to treat disease. In China, acupoint application with herbal medicine has been used in clinical treatment of angina pectoris, but there is no convincing evidence for the efficacy of acupoint application for angina pectoris, due to low methodologic quality and small sample size. The investigators designed the Randomized, Controlled, Double Blind clinical trial to investigates the efficacy of acupoint application in treating angina pectoris, the purpose of this study is to provide the convincing evidence for acupoint application treatment of angina pectoris.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Herbal application on acupoint group Containing the herbal medicine application on the specific acupoints plus foundation treatment |
Drug: Herbal plaster ( styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech)
Application containing herbal medicine that mainly include styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech and other herbal medicine.
Other Names:
Device: acupoint
select acupoint according to traditional Chinese medicine
Other Names:
Drug: Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.
foundation treatment
Other Names:
|
Placebo Comparator: Placebo application on acupoint Not containing herbal medicine application on the specific acupoints plus foundation treatment |
Device: acupoint
select acupoint according to traditional Chinese medicine
Other Names:
Drug: Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.
foundation treatment
Other Names:
|
Placebo Comparator: Herbal application on non-acupoint group Containing the herbal medicine application on the non-acupoints plus foundation treatment |
Drug: Herbal plaster ( styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech)
Application containing herbal medicine that mainly include styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech and other herbal medicine.
Other Names:
Drug: Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.
foundation treatment
Other Names:
|
Sham Comparator: Placebo application on non-acupoint Not containing herbal medicine application on the non-acupoints plus foundation treatment |
Drug: Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.
foundation treatment
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Change from Baseline Number of angina attacks at 12 weeks [at baseline,4, 8weeks after inclusion]
The change frequency of angina attack during every 4-week.
Secondary Outcome Measures
- Change from Baseline the severity of angina ( VAS score) at 12 weeks [at baseline,4, 8weeks after inclusion]
The VAS score evaluation angina pain severity
- Change from Baseline the dosage of nitroglycerin at 12 weeks [at baseline,4, 8weeks after inclusion]
Observed reduction in the dose of nitroglycerin
- Seattle Angina Questionnaire [at baseline,4, 8weeks after inclusion]
- self-rating anxiety scale [at baseline,4, 8weeks after inclusion]
- Self-rating Depression Scale [at baseline,4, 8weeks after inclusion]
Eligibility Criteria
Criteria
Inclusion Criteria:
1.Meet the diagnostic criteria of American College of Cardiology(ACC)/American Heart Association (AHA) angina pectoris of coronary heart disease.
2.35 ≤ age ≤ 85 years, both male and female.
3.The onset of angina pectoris≥3 months, and the frequency of angina attack≥2 a week.
4.Patients signed the informed consent
Exclusion Criteria:
-
age≤35 or age≥85.
-
Pregnant women or women in lactation or women of child bearing potential plan to conceive in the recent six months.
-
history of diabetes.
-
Co-infection or bleeding, allergic.
-
Currently participating in other clinical trials
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Affiliated hospital of Chengdu University of TCM | Chengdu | Sichuan | China | 610072 |
Sponsors and Collaborators
- Chengdu University of Traditional Chinese Medicine
Investigators
- Principal Investigator: Fanrong Liang, Chengdu University of TCM
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2011SZ0302.2